Detection of early-stage ovarian cancer by FDG-PET-CT in a patient with BRCA2-positive breast cancer.
University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
R Ashley
RA
Milam
Michael R
MR
Milam
Revathy B
RB
Iyer
D051017:Apoptosis Regulatory Proteins; D024682:BRCA2 Protein / Q000032:analysis*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000473:pathology / Q000628:therapy; D003537:Cystadenoma / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed
D051017:Apoptosis Regulatory Proteins; C118024:BLID protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human